Synapse

← William B. White

Papers by William B. White

Page 1 · newest first

  1. Treatment of Hypertension in Patients With Coronary Artery DiseaseJournal of the American College of Cardiology · 2015
  2. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialThe Lancet · 2019
  3. Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With HypertensionJournal of the American College of Cardiology · 2019
  4. Comparative analysis of machine learning and regularized regression models for predicting cardiovascular outcomes in patients with type 2 diabetes after acute coronary syndromeScientific Reports · 2026
  5. Average Daily Blood Pressure, Not Office Blood Pressure, Determines the Progression of Cerebrovascular Disease and Functional Decline in Older PersonsJournal of the American College of Cardiology · 2011
  6. Abstract FR498: Impact of Switching From High- to Low-Sodium Oxybate on Ambulatory and Office Blood Pressure in Subgroups of People With Narcolepsy From the XYLO StudyHypertension · 2025
  7. Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World StudyMayo Clinic Proceedings · 2024
  8. Risk of new-onset hypertension in patients (pts) with newly diagnosed chronic lymphocytic leukemia (CLL) treated with Bruton tyrosine kinase inhibitors (BTKi): A real-world data study using the Symphony Health Solution database.Journal of Clinical Oncology · 2024
  9. Risk of hypertension in patients with CLL/SLL who participated in ALPINE: A post hoc analysis.Journal of Clinical Oncology · 2024
  10. 0632 Design Elements for a Switch Study from High- to Low-Sodium Oxybate Evaluating Blood Pressure in Narcolepsy (XYLO)SLEEP · 2024
  11. A Dyadic Growth Modeling Approach for Examining Associations between Weight Gain and Lung Function Decline2024
  12. Proof of concept for quantitative adverse outcome pathway modeling of chronic toxicity in repeated exposureScientific Reports · 2024
  13. Creation and Validation of an Algorithm for Predicting the Recurrence of Atrial Fibrillation Following Pulmonary Vein Isolation by Utilizing Real-World Data and Ensemble Modeling TechniquesCureus · 2023
  14. Non-viral precision T cell receptor replacement for personalized cell therapyNature · 2022
  15. Effects of Oral Testosterone Undecanoate (Kyzatrex) Versus Testosterone Gel (Androgel) on Long-Term (to 12 Months) Blood Pressure LevelsAndrogens Clinical Research and Therapeutics · 2022
  16. External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trialDiabetes Obesity and Metabolism · 2022
  17. Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: apost hocanalysis of the TULIP-1 and TULIP-2 trialsLara D. Veeken · 2022
  18. Creation and Validation of an Algorithm Predicting Recurrence of Atrial Fibrillation Following Pulmonary Vein Isolation Utilizing Ensemble Modeling Techniques2022
  19. Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes TrialArthritis & Rheumatology · 2022
  20. Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney diseasePostgraduate Medicine · 2022
  21. Development of a Consensus-Based Definition of Focused Assessment With Sonography for Trauma in ChildrenJAMA Network Open · 2022
  22. Clinical factors associated with significant coronary lesions following out‐of‐hospital cardiac arrestAcademic Emergency Medicine · 2021
  23. Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trialCardiovascular Diabetology · 2021
  24. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of HypertensionJournal of Hypertension · 2021
  25. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal MenJournal of Cardiovascular Pharmacology and Therapeutics · 2021
  26. Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal menJournal of Clinical Hypertension · 2021
  27. Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trialDiabetes Obesity and Metabolism · 2021
  28. Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER TrialKidney360 · 2021
  29. Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( AMBER ): Results in the Pre-Specified Subgroup with Heart FailureEuropean Journal of Heart Failure · 2020
  30. A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal MenThe Journal of Clinical Endocrinology & Metabolism · 2020
  31. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE TrialJournal of the American Heart Association · 2020
  32. Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)Circulation · 2019
  33. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart AssociationHypertension · 2019
  34. Nocturnal blood pressure measured by home devicesJournal of Hypertension · 2018
  35. Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE TrialJournal of the American Heart Association · 2018
  36. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart AssociationHypertension · 2018
  37. Gout, Xanthine Oxidase Inhibition, and Cardiovascular OutcomesCirculation · 2018
  38. Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover StudyThe Journal of Clinical Pharmacology · 2018
  39. Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic HypertensionThe American Journal of Cardiology · 2018
  40. Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of goutLara D. Veeken · 2018
  41. Ambulatory blood pressure monitoring in the 21st centuryJournal of Clinical Hypertension · 2018
  42. Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE TrialDiabetes Care · 2018
  43. Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndromeClinical Cardiology · 2018
  44. Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY TrialThe Journal of Clinical Pharmacology · 2018
  45. A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effectsBlood Pressure Monitoring · 2018
  46. Longitudinal microstructural changes of cerebral white matter and their association with mobility performance in older personsPLoS ONE · 2018
  47. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with GoutNew England Journal of Medicine · 2018
  48. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced ConstipationJournal of Cardiovascular Pharmacology and Therapeutics · 2018
  49. Cardiorenal Safety of OTC AnalgesicsJournal of Cardiovascular Pharmacology and Therapeutics · 2018
  50. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 DiabetesClinical Journal of the American Society of Nephrology · 2018